Aug. 6 at 2:00 p.m. ET

Coronavirus: Vaccines and Treatments

When Albert Bourla took over as CEO of Pfizer in January 2019, he said he wanted the pharmaceutical giant to be a more focused, innovative, science-based company. Bourla now finds himself at the forefront of developing and testing a COVID-19 vaccine in partnership with Germany's BioNTech. Underway with a late-stage clinical trial for its vaccine, if successful, Pfizer said they could supply up to 100 million doses of the vaccine by the end of 2020. Bourla will discuss the timeline for a safe and effective vaccine and the state of the health industry during these uncertain times. Join Washington Post senior writer Frances Stead Sellers on Thursday, Aug. 6 at 2:00 p.m. ET.
Albert Bourla
Chairman and CEO , Pfizer
Dr. Albert Bourla is chairman and CEO of Pfizer. During his more than 25 years at Pfizer, he has held several senior global positions across a range of markets and disciplines. Before becoming CEO, he served as COO, overseeing commercial strategy, manufacturing, and global product development. Previously, he served as group president of Pfizer Innovative Health, which comprised the Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups. He also created the Patient and Health Impact group, dedicated to increasing patient access, demonstrating the value of Pfizer’s medicines, and broader business model innovation. Prior to that, he was president and GM of the Established Products business. He is a Doctor of Veterinary Medicine with a Ph.D. from the Veterinary School of Aristotle University and began his Pfizer career in 1993 in the Animal Health division. In 2020, Dr. Bourla was ranked America’s top CEO in the pharmaceuticals sector by Institutional Investor magazine. He is on the executive committee of the Partnership for New York City, a trustee of the US Council for International Business, and a director on multiple boards, including Pfizer Inc., the Pfizer Foundation, PhRMA, and Catalyst.
Frances Stead Sellers
The Washington Post
About Washington Post Live
Washington Post Live is the newsroom’s live journalism platform. Top-level government and business leaders, emerging voices and newsmakers discuss the most pressing national and global issues of the day.